AstraZeneca and its global biologics research and development arm, MedImmune, have chosen Cambridge as the base for a pioneering new genomics research centre.
{iframe}http://www.businessweekly.co.uk/news/biomedtech/az-injects-millions-new-genomics-nervecentre-cambridge{/iframe}